FDA Inspection 846018 — Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center

Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center — FEI 3010167719

The FDA completed an inspection of Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center on July 29, 2013 in Westerly, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 29, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Westerly, RI (United States)